Based in Los Angeles, Gary has 26 years of drug development experience, holding global leadership positions in Information Technology, Clinical Operations, and Quality Assurance.
Passionate about innovation and business transformation, Gary has spent the last 4 years working to advance industry adoption and regulatory acceptance of the virtual, decentralized and hybrid clinical trial models, and is currently exploring how elements of these may serve to streamline early phase clinical trials.